Dr. Lechtzin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 North Caroline Street
Baltimore, MD 21287Phone+1 410-550-5864Fax+1 410-367-2014
Summary
- Dr. Noah Lechtzin is an associate professor of medicine at the Johns Hopkins University School of Medicine. He holds a joint appointment in epidemiology at the Johns Hopkins Bloomberg School of Public Health. His areas of clinical expertise include amyotrophic lateral sclerosis (ALS), cystic fibrosis, adult pulmonary disease, and critical care medicine. Dr. Lechtzin serves as director of the Adult Cystic Fibrosis Program.
Dr. Lechtzin graduated first in his medical school class at Temple University, then did his internship and residency in internal medicine at Johns Hopkins. He completed a fellowship in pulmonary and critical care medicine at Johns Hopkins and also received an M.H.A. from the Johns Hopkins Bloomberg School of Public Health.
His research interests include the impact of antibiotic-resistant bacterial infections in cystic fibrosis (CF) patients and metabolic complications in CF, including vitamin D deficiency, osteoporosis, and testosterone deficiency.
Education & Training
- Johns Hopkins UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 1997 - 2001
- Johns Hopkins UniversityResidency, Internal Medicine, 1994 - 1997
- Lewis Katz School of Medicine at Temple UniversityClass of 1994
Certifications & Licensure
- MD State Medical License 1997 - 2026
- FL State Medical License 2013 - 2015
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Clinical Trials
- Nature Sights and Sounds to Reduce Pain in Cancer Patients Undergoing Bone Marrow Aspiration and Biopsy Start of enrollment: 2004 Aug 01
- Noninvasive Ventilation in ALS Patients With Mild Respiratory Involvement Start of enrollment: 2002 Apr 01
- Early Intervention in Cystic Fibrosis Exacerbation Start of enrollment: 2011 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- Racial disparities in lung transplantation for cystic fibrosis in the era of highly effective modulator therapy.Jessica M Ruck, Shi Nan Feng, Alexandra H Toporek, Pali D Shah, Erin Tallarico
Journal of Cystic Fibrosis. 2025-01-16 - Establishment of a conditionally reprogrammed primary eccrine sweat gland culture for evaluation of tissue-specific CFTR function.Alice C Eastman, Gedge Rosson, Noori Kim, Sewon Kang, Karen Raraigh
Journal of Cystic Fibrosis. 2024-11-01 - 2 citationsRemote endpoints for clinical trials in cystic fibrosis: Report from the U.S. CF foundation remote endpoints task force.Jordana E Hoppe, Jacquelyn Sjoberg, Gina Hong, Katie Poch, Edith T Zemanick
Journal of Cystic Fibrosis. 2024-07-01
Press Mentions
- Aridis Meets Primary and Secondary Endpoints in Phase 2a Study of AR-501 in Cystic Fibrosis PatientsMarch 13th, 2023
- New Approaches to Treating Infections in Cystic Fibrosis Patients - AR 501 Phase 2 Trial UpdateJanuary 17th, 2023
- Four Johns Hopkins Juniors Named Goldwater ScholarsApril 16th, 2021
- Join now to see all
Grant Support
- Early Intervention In Pulmonary Exacerbation In CFNational Heart, Lung, And Blood Institute2010–2011
- Improving Respiratory Outcomes In ALSNational Heart, Lung, And Blood Institute2002–2006
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/noah-lechtzin
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: